ArticleJPGN reports2022

Treatment of Inflammatory Bowel Disease and Pediatric Onset Multiple Sclerosis With Ocrelizumab and Ustekinumab in a JC-virus Positive Adolescent.

Kristin Lambert-Jenkins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.